Cardio Diagnostics Holdings, Inc.
CDIO
$3.99
$0.123.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.06% | -94.34% | -15.09% | -34.00% | 364.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.06% | -94.34% | -15.09% | -34.00% | 364.71% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -5.06% | -94.34% | -15.09% | -34.00% | 364.71% |
| SG&A Expenses | 30.68% | -61.91% | -1.64% | -0.37% | -49.16% |
| Depreciation & Amortization | -- | 845.83% | 10.42% | 0.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.68% | -60.91% | -1.71% | -2.66% | -49.50% |
| Operating Income | -30.89% | 60.78% | 1.66% | 2.44% | 49.77% |
| Income Before Tax | -30.68% | 60.73% | -9.39% | 26.90% | 67.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.68% | 60.73% | -9.39% | 26.90% | 67.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.68% | 60.73% | -9.39% | 26.90% | 67.98% |
| EBIT | -30.89% | 60.78% | 1.66% | 2.44% | 49.77% |
| EBITDA | -32.32% | 63.55% | 3.26% | 5.52% | 52.86% |
| EPS Basic | 43.37% | 83.64% | 47.22% | 64.40% | 85.49% |
| Normalized Basic EPS | 43.37% | 83.64% | 60.02% | 66.37% | 84.05% |
| EPS Diluted | 43.37% | 83.64% | 47.22% | 64.40% | 85.49% |
| Normalized Diluted EPS | 43.37% | 83.64% | 60.02% | 66.37% | 84.05% |
| Average Basic Shares Outstanding | 130.76% | 139.98% | 107.27% | 105.34% | 120.74% |
| Average Diluted Shares Outstanding | 130.76% | 139.98% | 107.27% | 105.34% | 120.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |